Ina Research Incorporation operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ina Research Incorporation with three other
pharmaceutical manufacturers in Asia:
Guangzhou Boji Medical & Biotechnological Co Ltd
sales of 172.04 million Chinese Renmimbi [US$24.25 million]
of which 61%
was Clinical research service),
Genetics Generation Advancement Corp
(381.66 million Taiwanese Dollars [US$12.43 million]
Biotoxtech Company Limited
based in South Korea
(32.58 billion Korean Won [US$27.47 million]
Ina Research Incorporation reported sales of ¥2.43 billion (US$22.29 million)
March of 2018.
increase of 5.7%
versus 2017, when the company's sales were ¥2.30 billion.